Mark Guinan
Director/Board Member bei UPHEALTH, INC.
Vermögen: 167 030 $ am 31.03.2024
Profil
Gegenwärtig hat Mark J. Guinan die Position des Chief Financial Officer & Executive Vice President bei Quest Diagnostics, Inc. inne. Herr Guinan ist außerdem Mitglied des Vorstands von Myovant Sciences Ltd., Q Squared Solutions Holdings Ltd. und Roivant Sciences, Inc. Zuvor hatte er die Position des Chief Financial Officer & Senior Vice President bei Hill-Rom Holdings, Inc. inne, war Vice President-Finance der Global Pharmaceutical Group, Chief Procurement Officer bei Johnson & Johnson und Principal bei Procter & Gamble Co. Mark J. Guinan erhielt einen Undergraduate-Abschluss von der University of Notre Dame und einen MBA von der Olin Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
UPHEALTH INC
0,86% | 31.01.2024 | 160 606 ( 0,86% ) | 167 030 $ | 31.03.2024 |
Aktive Positionen von Mark Guinan
Unternehmen | Position | Beginn |
---|---|---|
UPHEALTH, INC. | Director/Board Member | 05.12.2022 |
Q Squared Solutions Holdings Ltd.
Q Squared Solutions Holdings Ltd. Medical/Nursing ServicesHealth Services Part of IQVIA Holdings, Inc., Q Squared Solutions Holdings Ltd. is a British company that provides health services. The private company is based in Reading, UK. | Director/Board Member | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Director/Board Member | - |
Ehemalige bekannte Positionen von Mark Guinan
Unternehmen | Position | Ende |
---|---|---|
MYOVANT SCIENCES LTD. | Director/Board Member | 10.03.2023 |
QUEST DIAGNOSTICS INCORPORATED | Director of Finance/CFO | 11.07.2022 |
HILL-ROM HOLDINGS, INC. | Director of Finance/CFO | 19.07.2013 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2010 |
PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Ausbildung von Mark Guinan
University of Notre Dame | Undergraduate Degree |
Olin Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
JOHNSON & JOHNSON | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
QUEST DIAGNOSTICS INCORPORATED | Health Services |
UPHEALTH, INC. | Health Services |
Private Unternehmen | 5 |
---|---|
Hill-Rom Holdings, Inc.
Hill-Rom Holdings, Inc. Hospital/Nursing ManagementHealth Services Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL. | Health Services |
Global Pharmaceutical Group | |
Myovant Sciences Ltd.
Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Q Squared Solutions Holdings Ltd.
Q Squared Solutions Holdings Ltd. Medical/Nursing ServicesHealth Services Part of IQVIA Holdings, Inc., Q Squared Solutions Holdings Ltd. is a British company that provides health services. The private company is based in Reading, UK. | Health Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |